ReNeuron Group PLC

ReNeuron Group PLC

ReNeuron Group PLC

Overview
Date Founded

2005

Headquarters

Pencoed Business Park,Pencoed, Bridgend CF35 5HY

Type of Company

Public

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Medical Support Services
Biotechnology

Company Description

ReNeuron Group Plc engages in the development of novel cell based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom.

Executives & Employees

Scientific Co-Founder

Executive Director, Chief Executive Officer

Chief Financial Officer, Secretary & Executive Director

Chief Medical Officer

Chief Medical Officer

General Manager, Wales

Head of Research

Vice President Regulatory Affairs & Pharmacovigilence

Vice President, Business Development & Alliance Management

Vice President-Business Development & Alliance Management

Board of Directors

Former Executive Deputy Chairman at Oxxon Therapeutics, Inc.

Founder at Merlin Entertainments Group Operations Ltd.

Executive Chairman at Ieso Digital Health Ltd.

Chief Financial Officer, Secretary & Executive Director at ReNeuron Group PLC

Executive Director, Chief Executive Officer at ReNeuron Group PLC

Scientific Co-Founder at ReNeuron Group PLC

Venture Partner at Ysios Capital Partners SGEIC SA

Paths to ReNeuron Group PLC
Potential Connections via
Relationship Science
You
ReNeuron Group PLC
Owners & Shareholders
Details Hidden

Partners Investment Co. LLP is a private company headquartered in London, UK. The firm provides investment advice. It was founded in 2017 by Magnus Edward Spence-Jones.

Details Hidden

Carnegie-IM is an active, research-oriented manager which offers qualified advisory services in M&A, equity capital market transactions, as well as structured financial products. Their local presence gives them a unique understanding and expertise in Nordic industries and equity markets, as well as access to key persons and information flows.The firm advises Nordic transactions in sectors such as oil and gas, renewable energy, biotechnology and IT, as well as Nordic M&A transactions with links to Russia and parts of Eastern Europe.

Details Hidden

Suffolk Life Annuities Ltd., a subsidiary of Curtis Banks Group Plc, is a British company located in Ipswich that provides investment advice for insurance company portfolio. It was founded in 1971. William Arthur Self has been the CEO of the firm since 2003.The company says this about itself: SLA is a limited company incorporated and domiciled in the UK, and is a subsidiary of Curtis Banks Group Plc. SLA provides long-term linked life insurance products in the form of Self Invested Personal Pensions and other self invested products.

Recent Transactions
Details Hidden

ReNeuron Group PLC issued Ordinary Shares

Details Hidden

ReNeuron Group PLC issued Up to GBP Ordinary Shares

Details Hidden

ReNeuron Group PLC issued Ordinary Shares

Transaction Advisors
Investment Advisor

Advised onReNeuron Group PLC issued Ordinary Shares

Underwriter

Advised onReNeuron Group PLC issued Ordinary Shares

Auditor

Advised onReNeuron Group PLC issued Up to GBP Ordinary Shares

Professional

Advised onReNeuron Group PLC issued Ordinary Shares

Investment Advisor

Advised onReNeuron Group PLC issued Ordinary Shares

Investment Advisor

Advised onReNeuron Group PLC issued Ordinary Shares

Clients

Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consultingservices and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises businesses that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Key Stats and Financials As of 2019
Market Capitalization
$45.8M
Total Enterprise Value
$6.05M
Earnings Per Share
$-0.45
Revenue
$1.94M
Net Profit
$-14.3M
EBITDA
$-18.8M
EBITDAMargin
-966.94%
Total Debt
$0
Total Equity
$23.4M
Enterprise Value Sales
3.12x
TEVNet Income
-0.42x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
306.08%
Five Year Compounded Annual Growth Rate Of Revenue
145%
Suppliers
BioLife Solutions Inc. Industrial Machinery & Manufacturing | Bothell, Washington

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ReNeuron Group PLC. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ReNeuron Group PLC's profile does not indicate a business or promotional relationship of any kind between RelSci and ReNeuron Group PLC.